Growth Metrics

Intelligent Bio Solutions (INBS) Non-Current Debt (2022 - 2024)

Intelligent Bio Solutions' quarterly Non-Current Debt came in at $150426.0 in Q1 2024, down 68.05% year-on-year from $470872.0 in Q2 2023, and down 34.87% quarter-over-quarter from $230969.0 in Q4 2023.

Intelligent Bio Solutions has reported Non-Current Debt for 3 years, with the latest figure at $150426.0 in Q1 2024.

  • For the quarter ending Q1 2024, Non-Current Debt fell 68.05% year-over-year to $150426.0; the trailing twelve-month figure through Mar 2024 stood at $150426.0 (down 68.05% YoY), and the FY2023 full-year result was $402862.0, changed N/A from the prior year.
  • Non-Current Debt for Q1 2024 stood at $150426.0, down from $230969.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $507403.0 in Q4 2022, with the low at $150426.0 in Q1 2024.
  • Average Non-Current Debt over 3 years is $344794.3, with a median of $354548.0 recorded in 2023.
  • Year-over-year, Non-Current Debt plunged 54.48% in 2023 and slumped 68.05% in 2024.
  • Tracing INBS's Non-Current Debt over 3 years: stood at $507403.0 in 2022, then tumbled by 54.48% to $230969.0 in 2023, then sank by 34.87% to $150426.0 in 2024.
  • The last three Non-Current Debt figures came in at $150426.0 (Q1 2024), $230969.0 (Q4 2023), and $306234.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 29.64 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.22 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 27.88 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.81 Bn
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 150,426.00
Mar 31, 2024 150,426.00
Dec 31, 2023 230,969.00
Dec 31, 2023 230,969.00
Sep 30, 2023 306,234.00
Sep 30, 2023 306,234.00
Jun 30, 2023 402,862.00
Jun 30, 2023 402,862.00
Mar 31, 2023 470,872.00
Mar 31, 2023 470,872.00
Dec 31, 2022 507,403.00
Dec 31, 2022 507,403.00